What is Alta Partners?
Established in 1996, Alta Partners operates as a specialized venture capital firm with a primary focus on the biopharma and mobile care sectors. The firm distinguishes itself by identifying and supporting entrepreneurs who are actively challenging existing healthcare paradigms. By prioritizing companies that demonstrate the potential to improve patient outcomes, Alta Partners has built a robust portfolio that includes high-impact entities such as Allakos and DispatchHealth. Their market position is defined by a long-term investment horizon and a deep technical understanding of the complexities inherent in modern healthcare development.
How much funding has Alta Partners raised?
Alta Partners has raised a total of $130M across 1 funding round:
Other Financing Round
$130M
Other Financing Round (2017): $130M, investors not publicly disclosed
Key Investors in Alta Partners
Undisclosed Investors
What's next for Alta Partners?
Looking ahead, the recent influx of capital positions Alta Partners to accelerate its support for next-generation healthcare leaders. The firm is expected to deepen its involvement in home-based care delivery models and novel therapeutics, areas that are increasingly critical to the evolution of global health infrastructure. By maintaining a disciplined approach to strategic financing, Alta Partners remains well-equipped to navigate the regulatory and clinical hurdles that define the life sciences industry, ensuring that their portfolio companies are prepared for long-term scalability and market integration.
See full Alta Partners company page
